Commissariat a lEnergie Atomique et aux Energies Alternatives;Commissariat a l'Energie Atomique et aux Energies Alternatives
发明人:
Mouthon, Franck,Charveriat, Mathieu
申请号：
AU2012331136
公开号：
AU2012331136B2
申请日:
2012.10.31
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
This invention relates to improvements in therapeutic neurological and neuropsychic treatments using acetylcholinesterase inhibitors. More specifically, the invention enables the effects of the reversible acetylcholinesterase inhibitor donepezil to be potentiated by certain molecules, referred to here as connexin-blocking agents. Said connexin-blocking agent is preferably meclofenamic acid.
